{"aea2074e91c25104fd237ad28fb0c2e1aa1cbeec": [["A lthough the pandemic caused by SARS-CoV-2 is still ravaging most countries of the world 1,2 and containment measures are implemented worldwide 3 , a debate is emerging on whether these measures might be partially alleviated, and in case how and when [4] [5] [6] [7] [8] [9] .", [["SARS", "DISEASE", 33, 37], ["SARS-CoV-2", "ORGANISM", 33, 43], ["[4] [5] [6] [7] [8] [9]", "SIMPLE_CHEMICAL", 252, 275], ["SARS-CoV", "SPECIES", 33, 41], ["SARS", "PROBLEM", 33, 37]]]], "PMC7273953": [["We are in the midst of 2 deadly, concurrent public health emergencies: COVID-19 and the opioid crisis.", [["COVID", "TEST", 71, 76], ["the opioid crisis", "PROBLEM", 84, 101], ["opioid crisis", "OBSERVATION", 88, 101]]], ["Both are nationwide catastrophes that require immediate action to stem the tide of preventable death and disability.", [["death", "DISEASE", 95, 100], ["disability", "DISEASE", 105, 115], ["catastrophes", "PROBLEM", 20, 32], ["preventable death", "PROBLEM", 83, 100], ["catastrophes", "OBSERVATION", 20, 32]]], ["Even taking into account actions already taken, the novel coronavirus is forecast to take the lives of over 100,000 people in the United States,1 approximately the number lost to opioid overdose over the past 2 years.2", [["overdose", "DISEASE", 186, 194], ["coronavirus", "ORGANISM", 58, 69], ["people", "ORGANISM", 116, 122], ["people", "SPECIES", 116, 122], ["opioid overdose", "PROBLEM", 179, 194]]]], "PMC7134282": [["IntroductionThe initial idea to describe, understand, represent and design different dimensions of the enterprise was developed simultaneously within different disciplines in the late eighties.", [["late", "OBSERVATION_MODIFIER", 179, 183], ["eighties", "OBSERVATION_MODIFIER", 184, 192]]], ["He furthermore proposed the Zachman Framework for Enterprise Architecture (ZFEA) that he described as a logical, comprehensive structure \u201cfor classifying and organizing the descriptive representations of an Enterprise that are significant to the management of the Enterprise as well as to the development of the Enterprise\u2019s systems, manual systems as well as automated systems\u201d [1].IntroductionSince this original establishment of EA in the late 80\u2019s, EA has developed as a comprehensive discipline receiving interest from researchers and practitioners.", [["EA", "OBSERVATION_MODIFIER", 432, 434]]], ["Recent developments in the broad domain of EA include Enterprise Architecture Management (EAM) that elevates EA as a strategic business function rather than an IT function within organizations, and recent research indicate that EAM may indeed assist with organizational agility and transformation [17\u201321].IntroductionEA in strategic context is directed at the current and future purposes of the organization as well as to assist in reaching organisational goals and objectives, including ensuring that the business with its technologies and resources are aligned [10, 22].", [["EAM", "DISEASE", 228, 231], ["Enterprise Architecture Management", "TREATMENT", 54, 88], ["elevates EA", "PROBLEM", 100, 111]]], ["However, enterprises often experience challenges with the implementation of EA initiatives and capabilities [23], resulting in sentiments documented mostly in popular press, for instance stating that EA is dead [24, 25].", [["EA initiatives", "TREATMENT", 76, 90]]], ["Recent blog posts, for instance, claim that several EA frameworks or tools, specifically the ZFEA, are fake tools without any real value [26].", [["ZFEA", "DNA", 93, 97]]], ["EA is relevant for the IS domain as IS is the discipline concerned with studying socio-technical systems, and the view of theory within IS is therefore applicable to EA.", [["EA", "CANCER", 166, 168]]], ["The purpose of IS theories is to analyse, predict, explain and/or prescribe and it could be argued that the intent of EA often conforms to these purposes.IntroductionFor this paper we focus on the ZFEA primarily and we support this selection by analysing the foundational aspects of EA.", [["the ZFEA", "TREATMENT", 193, 201], ["this selection", "TREATMENT", 227, 241]]], ["We adopted the taxonomy of theories as well as the structural components of theory within IS as proposed by Gregor [28] to analyse the ZFEA.", [["ZFEA", "PROTEIN", 135, 139]]], ["The main research question answered by this study can be stated as follows: Given the nature and structure of theories within IS, could the ZFEA be considered as a theory?", [["ZFEA", "DNA", 140, 144], ["this study", "TEST", 39, 49], ["main", "OBSERVATION_MODIFIER", 4, 8]]], ["We then analyse the foundations of EA and motivate the choice of ZFEA for the purpose of this paper.", [["ZFEA", "SIMPLE_CHEMICAL", 65, 69], ["EA", "TREATMENT", 35, 37], ["ZFEA", "TREATMENT", 65, 69]]], ["We subsequently analyse the ZFEA given the nature of IS theories (taxonomy and structure) by Gregor, and we finally conclude.Enterprise Architecture ::: BackgroundEA originally developed from the need to align the business and information technology aspects of the organisation with one another [12], but has since advanced to be viewed from more than one perspective and for more than one application [10].", [["the ZFEA", "TREATMENT", 24, 32]]], ["Since its inception, several different EA frameworks were developed from different perspectives and disciplines.", [["several different EA frameworks", "PROBLEM", 21, 52], ["several", "OBSERVATION_MODIFIER", 21, 28], ["different", "OBSERVATION_MODIFIER", 29, 38], ["EA", "OBSERVATION_MODIFIER", 39, 41]]], ["Due to space limitations, we will mostly focus on the ZFEA, however, several works on the history, evolution, purpose of, and recent developments within EA are included as references [3, 12, 13, 16, 17, 32\u201338].", [["space", "OBSERVATION", 7, 12]]], ["4 we analyse the grounding of the EA discipline to motivate the choice of the ZFEA for this paper, and in the next section a short overview of ZFEA is provided.The Zachman Framework for Enterprise Architecture (ZFEA) ::: BackgroundJohn Zachman is widely acknowledged as the father of EA [16, 39].", [["ZFEA", "CANCER", 143, 147], ["ZFEA", "DNA", 143, 147], ["the EA discipline", "TREATMENT", 30, 47]]], ["Borrowing from the field of engineering, Zachman described how insight into different disciplines and the manufacturing process contributed to the ZFEA [1, 40].", [["the manufacturing process", "PROBLEM", 102, 127]]], ["Zachman describes the breakthrough that led to his now well-known ZFEA as the realisation of the existence of different perspectives relevant to a product, which he then applied to an enterprise [39].", [["Zachman", "TREATMENT", 0, 7]]], ["The ZFEA is also described as an enterprise ontology with no process or tooling implications [41], or a meta-model of an enterprise represented in a matrix comprised of columns and rows.", [["matrix", "CELLULAR_COMPONENT", 149, 155], ["ZFEA", "DNA", 4, 8], ["tooling implications", "PROBLEM", 72, 92]]], ["Each intersection of a column and row provides a unique representation or view of the enterprise [1].", [["a column and row", "TREATMENT", 21, 37], ["column", "ANATOMY", 23, 29]]]], "acbcac3aeb5c5275f611cc2fe5ed1f8650268f72": [["Inclusion Criteria ICD-10 Codes Hypertension I10%, I11%, I12%, I13%, I15%, I16%, I67 G468, I690, G462, I606, G452, I682, I613, I634, I650, I668, I662, I670, G463, I679, I673, H340, I607, I669, G464, I692, I699, G454, I691, I620, I660, I658, I605, I635, I608, G461, I602, I616, G458, I676, I604, I699, I621, I600, I677, I672", [["Hypertension", "DISEASE", 32, 44], ["I677", "DNA", 313, 317], ["I672", "DNA", 319, 323], ["ICD", "TEST", 19, 22], ["Hypertension", "TEST", 32, 44], ["I11", "TEST", 51, 54], ["I12", "TEST", 57, 60], ["G462", "TEST", 97, 101], ["G452", "TEST", 109, 113], ["G463", "TEST", 157, 161], ["H340", "TEST", 175, 179], ["G464", "TEST", 193, 197], ["G454", "TEST", 211, 215], ["I605", "TEST", 241, 245], ["G461", "TEST", 259, 263], ["I602", "TEST", 265, 269], ["G458", "TEST", 277, 281], ["I604", "TEST", 289, 293], ["ICD", "OBSERVATION", 19, 22]]]], "PMC7253765": [["School closures are an important strategy to mitigate the impacts of a pandemic.1,2 However, an optimal approach to transitioning from in-person to distance learning approaches is lacking.3 We analyzed a convenience sample of public K-12 schools in the early weeks of the coronavirus disease\u20132019 (COVID-19) pandemic in the United States.", [["coronavirus disease", "DISEASE", 272, 291], ["School closures", "TREATMENT", 0, 15], ["a pandemic", "PROBLEM", 69, 79], ["public K", "TEST", 226, 234], ["the coronavirus disease", "PROBLEM", 268, 291], ["COVID", "TEST", 298, 303], ["coronavirus disease", "OBSERVATION", 272, 291]]]], "PMC7121624": [["Historical Background ::: IntroductionEllipsometry was used already 1932 for studies of organic monolayers by Tronsted et al. [1], but Vroman [2], Rothen and Mathot [3] and Stromberg et al. [4] were most likely among the first to report measurements on protein layers.", [["monolayers", "CELL", 96, 106], ["organic monolayers", "TEST", 88, 106], ["Vroman", "TEST", 135, 141], ["Rothen", "TEST", 147, 153], ["Stromberg et al.", "TEST", 173, 189]]], ["Azzam et al. [5] demonstrated similar results in studies of immunological reactions and also provided a theoretical framework.", [["immunological reactions", "PROBLEM", 60, 83]]], ["Their pioneering work included studies of kinetics of protein adsorption at solid/liquid interfaces.", [["protein adsorption at solid/liquid interfaces", "PROBLEM", 54, 99], ["liquid interfaces", "OBSERVATION", 82, 99]]], ["These early investigators found ellipsometry to be a suitable tool for non-destructive analysis of thin films, both ex situ as well as in situ at a solid/liquid interface, but surprisingly the use of the technique for protein adsorption studies during the last 40 years has been limited to a few laboratories.1 In addition, with a few exceptions, the types of applications are generally very simple and often limited to single wavelength measurements.", [["non-destructive analysis", "TEST", 71, 95], ["thin films", "TEST", 99, 109], ["a solid/liquid interface", "TREATMENT", 146, 170], ["the technique", "TREATMENT", 200, 213], ["protein adsorption studies", "TEST", 218, 244], ["single wavelength measurements", "TEST", 420, 450], ["few", "OBSERVATION_MODIFIER", 331, 334]]], ["This may be due to that most users in the field have a background in biochemistry or medicine and not are sufficiently trained in optics and physics to make full use of the technique.", [["the technique", "TREATMENT", 169, 182], ["may be due to", "UNCERTAINTY", 5, 18]]], ["The development in the field during this period has been reviewed several times [6\u201313].Historical Background ::: IntroductionHowever, one also finds that about one third of the reports are from the last ten years and new research groups have started to use ellipsometry and more advanced methodology is employed.", [["ellipsometry", "TREATMENT", 257, 269]]], ["The applications of the technique on protein adsorption have now expanded to include imaging ellipsometry [14], total internal reflection ellipsometry [15\u201317], infrared ellipsometry [18, 19], in combination with quartz micro balance [20, 21] and more.", [["quartz", "CHEMICAL", 212, 218], ["the technique on protein adsorption", "TREATMENT", 20, 55], ["imaging ellipsometry", "TEST", 85, 105], ["total internal reflection ellipsometry", "TEST", 112, 150], ["infrared ellipsometry", "TEST", 160, 181], ["quartz micro balance", "TEST", 212, 232]]], ["Fortunately spectroscopy becomes more and more common and attempts are made to address scientific issues beyond semi-quantitative analysis of layer thickness and simple determination of surface mass density.Opportunities and Challenges ::: IntroductionEllipsometry offers possibilities for true quantitative measurement of thin layers with sub-nm sensitivity and has the in situ advantage to allow monitoring of dynamic processes.", [["surface", "ANATOMY", 186, 193], ["layers", "TISSUE", 328, 334], ["Fortunately spectroscopy", "TEST", 0, 24], ["layer thickness", "PROBLEM", 142, 157], ["surface mass density", "PROBLEM", 186, 206], ["thin layers", "PROBLEM", 323, 334], ["sub-nm sensitivity", "PROBLEM", 340, 358], ["layer thickness", "OBSERVATION_MODIFIER", 142, 157], ["surface", "OBSERVATION_MODIFIER", 186, 193], ["mass", "OBSERVATION", 194, 198]]], ["It is based on photons-in photons-out and is thus nondestructive and can be applied even at a solid/liquid interface.Opportunities and Challenges ::: IntroductionThe in situ advantage should not be underestimated for protein adsorption studies because: (1) protein layers can to be studied on model surfaces very similar to those in the normal environment for proteins; (2) protein layer surface dynamics can be studied directly; and (3) no labeling of protein molecules is required.", [["surface", "ANATOMY", 388, 395], ["protein molecules", "PROTEIN", 453, 470], ["a solid/liquid interface", "TREATMENT", 92, 116], ["protein adsorption studies", "TEST", 217, 243], ["protein layers", "PROBLEM", 257, 271], ["protein layer surface dynamics", "TEST", 374, 404], ["labeling of protein molecules", "PROBLEM", 441, 470], ["nondestructive", "OBSERVATION_MODIFIER", 50, 64]]], ["These three characteristics facilitate studies of central phenomena in protein adsorption research including competitive adsorption of proteins, protein layer structure and dynamics, protein interaction on surfaces and protein exchange reactions and more.", [["central phenomena in protein adsorption research", "PROBLEM", 50, 98], ["competitive adsorption of proteins", "TREATMENT", 109, 143], ["protein layer structure", "PROBLEM", 145, 168], ["protein exchange reactions", "TREATMENT", 219, 245], ["central phenomena", "OBSERVATION", 50, 67]]], ["Studies under flow is an example on an additional possibility.", [["flow", "OBSERVATION", 14, 18]]], ["It is no doubt that ellipsometry is a convenient and excellent tool to study surface dynamics in biological systems.", [["surface", "ANATOMY", 77, 84], ["no doubt", "UNCERTAINTY", 6, 14]]], ["We may distinguish between basic research on protein adsorption performed in research laboratories and biosensor applications with goal to get established in clinical laboratories and even in the doctors office.", [["protein adsorption", "TREATMENT", 45, 63], ["biosensor applications", "TREATMENT", 103, 125]]], ["For the research applications, the available ellipsometers on the market have precision, speed and general performance to match the requirements for high-precision bioadsorption studies.", [["high-precision bioadsorption studies", "TEST", 149, 185]]], ["It is fair to say that the instrument problem is solved in this context.", [["the instrument problem", "PROBLEM", 23, 45]]], ["Of course, depending on the actual scientific question addressed, there are always technical challenges related to how to expose proteins to a surface: in situ or ex situ adsorption; flowing or static adsorption conditions; solution stirring or not; temperature control; etc.Opportunities and Challenges ::: IntroductionWith the instrument problem solved, the two most important scientific challenges are the data evaluation and to select the most appropriate surface for the problem addressed.", [["surface", "ANATOMY", 143, 150], ["surface", "ANATOMY", 460, 467], ["surface", "CELLULAR_COMPONENT", 143, 150], ["static adsorption conditions", "TREATMENT", 194, 222], ["solution stirring", "TREATMENT", 224, 241], ["the data evaluation", "TEST", 405, 424]]], ["In in vitro studies of protein adsorption one may always question if the model surface used is relevant.", [["surface", "ANATOMY", 79, 86], ["protein adsorption", "TREATMENT", 23, 41]]], ["Ellipsometry has this problem in common with many other techniques but a special limitation for ellipsometry is that a relatively flat surface at least a few square mm", [["surface", "ANATOMY", 135, 142]]]], "e5d7b78cf1acf78071a1b54e6f4fe6dd68ac9430": [["HDLs are composed of a heterogeneous group of lipidprotein complexes that circulate in the blood.", [["blood", "ANATOMY", 91, 96], ["HDLs", "SIMPLE_CHEMICAL", 0, 4], ["lipidprotein", "GENE_OR_GENE_PRODUCT", 46, 58], ["blood", "ORGANISM_SUBSTANCE", 91, 96], ["lipidprotein complexes", "PROTEIN", 46, 68], ["a heterogeneous group of lipidprotein complexes", "PROBLEM", 21, 68], ["heterogeneous", "OBSERVATION_MODIFIER", 23, 36], ["blood", "ANATOMY", 91, 96]]], ["HDLcholesterol (HDL-C) levels exhibit strong inverse correlations with coronary artery disease (CAD) in many populations (1, 2) , and their (3, 4) abilities to promote reverse cholesterol transport and suppress inflammatory responses are consistent with the concept that they protect against the disease (5, 6) .", [["coronary artery", "ANATOMY", 71, 86], ["HDLcholesterol", "CHEMICAL", 0, 14], ["HDL-C", "CHEMICAL", 16, 21], ["coronary artery disease", "DISEASE", 71, 94], ["CAD", "DISEASE", 96, 99], ["cholesterol", "CHEMICAL", 176, 187], ["HDLcholesterol", "CHEMICAL", 0, 14], ["cholesterol", "CHEMICAL", 176, 187], ["HDLcholesterol", "SIMPLE_CHEMICAL", 0, 14], ["HDL-C", "SIMPLE_CHEMICAL", 16, 21], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 71, 86], ["cholesterol", "SIMPLE_CHEMICAL", 176, 187], ["HDL", "PROTEIN", 16, 19], ["HDLcholesterol (HDL-C) levels", "TREATMENT", 0, 29], ["coronary artery disease", "PROBLEM", 71, 94], ["CAD", "PROBLEM", 96, 99], ["reverse cholesterol transport", "TREATMENT", 168, 197], ["the disease", "PROBLEM", 292, 303], ["coronary artery", "ANATOMY", 71, 86], ["disease", "OBSERVATION", 87, 94], ["inflammatory", "OBSERVATION", 211, 223], ["disease", "OBSERVATION", 296, 303]]], ["However, evidence from genome-wide association studies (GWASs) has suggested that association with CAD may not be causal (7) .", [["CAD", "DISEASE", 99, 102], ["CAD", "PROBLEM", 99, 102]]], ["Certain alleles that raise HDL-C levels at GWAS loci were not associated with protection against CAD in \"Mendelian randomization\" studies.", [["CAD", "DISEASE", 97, 100], ["HDL-C", "GENE_OR_GENE_PRODUCT", 27, 32], ["HDL", "PROTEIN", 27, 30], ["GWAS loci", "DNA", 43, 52], ["Certain alleles", "PROBLEM", 0, 15], ["HDL", "TEST", 27, 30], ["C levels at GWAS loci", "PROBLEM", 31, 52], ["CAD", "PROBLEM", 97, 100]]], ["Additionally, clinical traits with drugs that raise HDL-C did not show protection against CAD additional to the statin effect.", [["CAD", "DISEASE", 90, 93], ["statin", "CHEMICAL", 112, 118], ["HDL-C", "SIMPLE_CHEMICAL", 52, 57], ["HDL", "PROTEIN", 52, 55], ["drugs", "TREATMENT", 35, 40], ["HDL", "TEST", 52, 55], ["CAD", "PROBLEM", 90, 93], ["the statin effect", "TREATMENT", 108, 125]]], ["It has been suggested that the discrepancy may be explained by the heterogeneity of HDL (8) .", [["HDL", "SIMPLE_CHEMICAL", 84, 87], ["HDL", "TEST", 84, 87], ["may be explained", "UNCERTAINTY", 43, 59]]], ["Thus, it is possible that certain species of HDL, but not others, provide Abstract HDLs are nanoparticles with more than 80 associated proteins, phospholipids, cholesterol, and cholesteryl esters.", [["cholesterol", "CHEMICAL", 160, 171], ["cholesteryl esters", "CHEMICAL", 177, 195], ["cholesterol", "CHEMICAL", 160, 171], ["cholesteryl esters", "CHEMICAL", 177, 195], ["HDL", "SIMPLE_CHEMICAL", 45, 48], ["HDLs", "GENE_OR_GENE_PRODUCT", 83, 87], ["phospholipids", "SIMPLE_CHEMICAL", 145, 158], ["cholesterol", "SIMPLE_CHEMICAL", 160, 171], ["cholesteryl esters", "SIMPLE_CHEMICAL", 177, 195], ["certain species of HDL", "PROBLEM", 26, 48], ["phospholipids", "TEST", 145, 158], ["cholesterol", "TEST", 160, 171]]], ["The potential inverse relation of HDL to coronary artery disease (CAD) and the effects of HDL on myriad other inflammatory conditions warrant a better understanding of the genetic basis of the HDL proteome.", [["coronary artery", "ANATOMY", 41, 56], ["HDL", "ANATOMY", 193, 196], ["coronary artery disease", "DISEASE", 41, 64], ["CAD", "DISEASE", 66, 69], ["HDL", "SIMPLE_CHEMICAL", 34, 37], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 41, 56], ["HDL", "SIMPLE_CHEMICAL", 90, 93], ["HDL", "GENE_OR_GENE_PRODUCT", 193, 196], ["HDL", "PROTEIN", 34, 37], ["coronary artery disease", "PROBLEM", 41, 64], ["CAD", "PROBLEM", 66, 69], ["HDL on myriad other inflammatory conditions", "PROBLEM", 90, 133], ["coronary artery", "ANATOMY", 41, 56], ["disease", "OBSERVATION", 57, 64], ["inflammatory", "OBSERVATION", 110, 122]]], ["We conducted a comprehensive genetic analysis of the regulation of the proteome of HDL isolated from a panel of 100 diverse inbred strains of mice (the hybrid mouse diversity panel) and examined protein composition and efflux capacity to identify novel factors that affect the HDL proteome.", [["HDL", "ANATOMY", 83, 86], ["HDL", "GENE_OR_GENE_PRODUCT", 83, 86], ["mice", "ORGANISM", 142, 146], ["mouse", "ORGANISM", 159, 164], ["HDL", "SIMPLE_CHEMICAL", 277, 280], ["HDL", "PROTEIN", 83, 86], ["mice", "SPECIES", 142, 146], ["mouse", "SPECIES", 159, 164], ["mice", "SPECIES", 142, 146], ["mouse", "SPECIES", 159, 164], ["a comprehensive genetic analysis", "TEST", 13, 45], ["HDL", "TEST", 83, 86], ["a panel", "TEST", 101, 108], ["protein composition", "PROBLEM", 195, 214], ["efflux capacity", "PROBLEM", 219, 234], ["novel factors", "PROBLEM", 247, 260]]], ["Genetic analysis revealed widely varied HDL protein levels across the strains.", [["HDL", "GENE_OR_GENE_PRODUCT", 40, 43], ["HDL protein", "PROTEIN", 40, 51], ["Genetic analysis", "TEST", 0, 16], ["widely varied HDL protein levels across the strains", "PROBLEM", 26, 77], ["widely", "OBSERVATION_MODIFIER", 26, 32], ["varied", "OBSERVATION_MODIFIER", 33, 39], ["HDL protein levels", "OBSERVATION", 40, 58]]], ["Some of this variation was explained by local cis-acting regulation, termed cis-protein quantitative trait loci (QTLs).", [["cis-protein quantitative trait loci", "GENE_OR_GENE_PRODUCT", 76, 111], ["cis-protein quantitative trait loci", "DNA", 76, 111], ["QTLs", "DNA", 113, 117]]], ["Variations in apoA-II and apoC-3 affected the abundance of multiple HDL proteins, indicating a coordinated regulation.", [["apoA-II", "CHEMICAL", 14, 21], ["apoA-II", "GENE_OR_GENE_PRODUCT", 14, 21], ["apoC-3", "GENE_OR_GENE_PRODUCT", 26, 32], ["HDL", "GENE_OR_GENE_PRODUCT", 68, 71], ["apoA-II", "PROTEIN", 14, 21], ["apoC-3", "PROTEIN", 26, 32], ["HDL proteins", "PROTEIN", 68, 80], ["Variations", "TEST", 0, 10], ["apoA", "TEST", 14, 18], ["apoC", "TEST", 26, 30], ["multiple HDL proteins", "PROBLEM", 59, 80]]], ["We identified modules of covarying proteins and defined a protein-protein interaction network that describes the protein composition of the naturally occurring subspecies of HDL in mice.", [["HDL", "ANATOMY", 174, 177], ["HDL", "SIMPLE_CHEMICAL", 174, 177], ["mice", "ORGANISM", 181, 185], ["covarying proteins", "PROTEIN", 25, 43], ["protein-protein interaction network", "PROTEIN", 58, 93], ["HDL", "PROTEIN", 174, 177], ["mice", "SPECIES", 181, 185], ["mice", "SPECIES", 181, 185], ["covarying proteins", "PROBLEM", 25, 43], ["a protein-protein interaction network", "PROBLEM", 56, 93]]], ["Sterol efflux capacity varied up to 3-fold across the strains, and HDL proteins displayed distinct correlation patterns with macrophage and ABCA1specific cholesterol efflux capacity and cholesterol exchange, suggesting that subspecies of HDL participate in discrete functions.", [["macrophage", "ANATOMY", 125, 135], ["cholesterol", "CHEMICAL", 154, 165], ["cholesterol", "CHEMICAL", 186, 197], ["Sterol", "CHEMICAL", 0, 6], ["cholesterol", "CHEMICAL", 154, 165], ["cholesterol", "CHEMICAL", 186, 197], ["Sterol", "SIMPLE_CHEMICAL", 0, 6], ["HDL", "GENE_OR_GENE_PRODUCT", 67, 70], ["macrophage", "CELL", 125, 135], ["ABCA1specific", "SIMPLE_CHEMICAL", 140, 153], ["cholesterol", "SIMPLE_CHEMICAL", 154, 165], ["cholesterol", "SIMPLE_CHEMICAL", 186, 197], ["HDL", "SIMPLE_CHEMICAL", 238, 241], ["HDL proteins", "PROTEIN", 67, 79], ["Sterol efflux capacity", "TEST", 0, 22], ["the strains", "TEST", 50, 61], ["HDL proteins", "TEST", 67, 79], ["macrophage", "PROBLEM", 125, 135], ["ABCA1specific cholesterol efflux capacity", "PROBLEM", 140, 181], ["cholesterol exchange", "TEST", 186, 206], ["efflux capacity", "OBSERVATION", 7, 22], ["macrophage", "OBSERVATION", 125, 135], ["cholesterol efflux", "OBSERVATION", 154, 172]]], ["The baseline and stimulated sterol efflux capacity phenotypes were associated with distinct QTLs with smaller effect size, suggesting a multigenetic regulation.", [["sterol", "CHEMICAL", 28, 34], ["sterol", "SIMPLE_CHEMICAL", 28, 34], ["The baseline and stimulated sterol efflux capacity phenotypes", "PROBLEM", 0, 61], ["distinct QTLs", "PROBLEM", 83, 96], ["smaller effect size", "PROBLEM", 102, 121], ["a multigenetic regulation", "TREATMENT", 134, 159], ["efflux capacity", "OBSERVATION", 35, 50], ["smaller", "OBSERVATION_MODIFIER", 102, 109], ["effect", "OBSERVATION_MODIFIER", 110, 116], ["size", "OBSERVATION_MODIFIER", 117, 121], ["multigenetic regulation", "OBSERVATION", 136, 159]]], ["Our results highlight the complexity of HDL particles by revealing protection against CAD, and that the genetic or drug perturbations failed to impact those mediating the protection.", [["HDL particles", "ANATOMY", 40, 53], ["CAD", "DISEASE", 86, 89], ["HDL", "SIMPLE_CHEMICAL", 40, 43], ["HDL particles", "TREATMENT", 40, 53], ["CAD", "PROBLEM", 86, 89], ["drug perturbations", "PROBLEM", 115, 133]]], ["In particular, certain population studies have found that the efficiency of HDL in mediating cholesterol efflux from cells has been associated with decreased incidence of CAD (9) (10) (11) .", [["cells", "ANATOMY", 117, 122], ["cholesterol", "CHEMICAL", 93, 104], ["CAD", "DISEASE", 171, 174], ["cholesterol", "CHEMICAL", 93, 104], ["HDL", "SIMPLE_CHEMICAL", 76, 79], ["cholesterol", "SIMPLE_CHEMICAL", 93, 104], ["cells", "CELL", 117, 122], ["HDL", "PROTEIN", 76, 79], ["certain population studies", "TEST", 15, 41], ["HDL in mediating cholesterol efflux from cells", "PROBLEM", 76, 122], ["CAD", "PROBLEM", 171, 174], ["cholesterol efflux", "OBSERVATION", 93, 111], ["decreased", "OBSERVATION_MODIFIER", 148, 157], ["CAD", "OBSERVATION", 171, 174]]], ["In addition to CAD, HDL is likely to mediate a variety of immune and regulatory functions (12) (13) (14) .", [["CAD", "DISEASE", 15, 18], ["HDL", "SIMPLE_CHEMICAL", 20, 23], ["HDL", "PROTEIN", 20, 23], ["CAD", "PROBLEM", 15, 18], ["HDL", "TEST", 20, 23], ["CAD", "OBSERVATION", 15, 18], ["likely to", "UNCERTAINTY", 27, 36]]], ["Because these protective functions are most likely regulated by the proteins associated with HDL, understanding the regulation of the HDL subpopulation's proteome heterogeneity is imperative.", [["HDL", "GENE_OR_GENE_PRODUCT", 93, 96], ["HDL", "GENE_OR_GENE_PRODUCT", 134, 137], ["HDL", "TREATMENT", 93, 96], ["most likely", "UNCERTAINTY", 39, 50]]]], "d5d0bd7a92f0d2f724f01af430a7e501045c317d": [["Commentwww.thelancet.com/public-health Vol 5 March 2020 e135Authoritarianism, outbreaks, and information politicsAre autocratic states such as China better equipped than their more democratic counterparts to respond to disease outbreaks?", [["disease outbreaks", "PROBLEM", 219, 236]]], ["On Dec 31, 2019, China alerted WHO to an outbreak of pneumonia of unknown cause in the city of Wuhan in Hubei province.", [["pneumonia", "DISEASE", 53, 62], ["pneumonia", "PROBLEM", 53, 62], ["pneumonia", "OBSERVATION", 53, 62]]], ["The epidemic quickly spread, with cases of a novel coronavirus (2019-nCoV) confirmed throughout China and elsewhere in Asia, Europe, North America, and Australia.", [["coronavirus", "DISEASE", 51, 62], ["coronavirus", "ORGANISM", 51, 62], ["a novel coronavirus", "PROBLEM", 43, 62], ["epidemic", "OBSERVATION_MODIFIER", 4, 12]]], ["On the surface, the power of authoritarianism is on display in China's response to 2019-nCoV.", [["surface", "ANATOMY", 7, 14], ["surface", "CELLULAR_COMPONENT", 7, 14], ["surface", "OBSERVATION_MODIFIER", 7, 14], ["power", "OBSERVATION_MODIFIER", 20, 25], ["authoritarianism", "OBSERVATION", 29, 45]]], ["The Huanan seafood market suspected as the outbreak source was closed and decontaminated within a day of the announcement.", [["The Huanan seafood market", "TREATMENT", 0, 25]]], ["Within 3 days of confirmed human-tohuman transmission, with cases rising and the world's largest mass travel event underway for the lunar new year Spring Festival, the Chinese Government imposed an unprecedented cordon sanitaire.", [["human-tohuman transmission", "DISEASE", 27, 53], ["human", "ORGANISM", 27, 32], ["human", "SPECIES", 27, 32], ["human", "SPECIES", 27, 32], ["an unprecedented cordon sanitaire", "TREATMENT", 195, 228], ["largest", "OBSERVATION_MODIFIER", 89, 96], ["mass", "OBSERVATION", 97, 101]]], ["Movement of more than 50 million people across Hubei province was rapidly restricted, curtailing transportation inside cities and outbound transportation by air, train, and bus.", [["people", "ORGANISM", 33, 39], ["people", "SPECIES", 33, 39]]], ["5 Yet, time is key to controlling outbreaks; getting good information and acting on it rapidly can halt outbreaks before they need emergency measures.", [["emergency measures", "TREATMENT", 131, 149]]], ["The early history of the 2019-nCoV outbreak raises questions about whether this situation is an example of beneficial autocracy.Authoritarianism, outbreaks, and information politicsFor Amartya Sen, authoritarian states face serious challenges in information and accountability.", [["Authoritarianism", "DISEASE", 128, 144], ["beneficial autocracy", "PROBLEM", 107, 127], ["Authoritarianism", "PROBLEM", 128, 144]]], ["Governments can be the victims of their own propaganda, because the country's political institutions provide incentives to local officials to avoid sharing bad news with their central bosses and await instructions before acting.Authoritarianism, outbreaks, and information politicsInformation politics in China undermined a rapid response to the 2019-nCoV outbreak.", [["Authoritarianism", "DISEASE", 228, 244]]], ["8 Police detained a clinician and seven other people posting reports on 2019-nCoV, threatening punishment for spreading socalled rumors.", [["people", "ORGANISM", 46, 52], ["people", "SPECIES", 46, 52], ["spreading socalled rumors", "PROBLEM", 110, 135]]], ["Social media was censored; a preliminary analysis of Weibo and WeChat published on China's biggest online platform 9 showed outbreak discussions were nearly non-existent through much of January, 2020, until the Chinese Government changed its official stance on Jan 20, 2020.Authoritarianism, outbreaks, and information politicsThrough much of January, 2020, the Wuhan Municipal Health Commission reported no evidence of human-to-human transmission, no infection among health workers, that severe cases of disease caused by 2019-nCoV infection were confined to those with underlying conditions and older people, and that the Huanan seafood market was the source.", [["Authoritarianism", "DISEASE", 274, 290], ["human-to-human transmission", "DISEASE", 420, 447], ["infection", "DISEASE", 452, 461], ["infection", "DISEASE", 533, 542], ["human", "ORGANISM", 420, 425], ["human", "ORGANISM", 429, 434], ["people", "ORGANISM", 603, 609], ["human", "SPECIES", 420, 425], ["human", "SPECIES", 429, 434], ["people", "SPECIES", 603, 609], ["human", "SPECIES", 420, 425], ["human", "SPECIES", 429, 434], ["a preliminary analysis", "TEST", 27, 49], ["infection", "PROBLEM", 452, 461], ["disease", "PROBLEM", 505, 512], ["nCoV infection", "PROBLEM", 528, 542], ["the Huanan seafood market", "TREATMENT", 620, 645], ["no evidence of", "UNCERTAINTY", 405, 419], ["severe", "OBSERVATION_MODIFIER", 489, 495]]], ["11 Reports in The Lancet 7 and New England Journal of Medicine, 12 however, show that half of patients admitted to intensive-care units were aged 25-49 years, and two-thirds had no underlying illnesses.", [["patients", "ORGANISM", 94, 102], ["patients", "SPECIES", 94, 102], ["underlying illnesses", "PROBLEM", 181, 201], ["illnesses", "OBSERVATION", 192, 201]]], ["Human-tohuman transmission and health-worker infection were evident before the Chinese Government made an announcement.", [["Human-tohuman transmission and health-worker infection", "DISEASE", 0, 54], ["Human", "ORGANISM", 0, 5], ["Human", "SPECIES", 0, 5], ["infection", "PROBLEM", 45, 54], ["infection", "OBSERVATION", 45, 54]]], ["10 By the time quarantine went into effect on Jan 23, 2020, five million people had left the city of Wuhan for holiday travel.", [["people", "ORGANISM", 73, 79], ["people", "SPECIES", 73, 79]]], ["10 Outbreaks were subsequently reported throughout China.Authoritarianism, outbreaks, and information politicsWithout open media and an opposition to check on bureaucratic hierarchy, knowledge from the front lines of the 2019-nCoV outbreak did not reach Beijing.", [["Authoritarianism", "DISEASE", 57, 73], ["open media", "TREATMENT", 118, 128]]]], "30f11689ff54b3307f2d8c914d0ee13438f5b15d": [["The attachment of SARS-CoV-2 to cell membrane is the initial step of the pathogenesis of COVID-19, in which the viral spike (S) protein that can be divided into S1 and S2 subunits after degradation by protease is attributable.", [["cell membrane", "ANATOMY", 32, 45], ["SARS", "DISEASE", 18, 22], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 18, 28], ["cell membrane", "CELLULAR_COMPONENT", 32, 45], ["COVID-19", "CELL", 89, 97], ["S1", "GENE_OR_GENE_PRODUCT", 161, 163], ["S2", "GENE_OR_GENE_PRODUCT", 168, 170], ["viral spike (S) protein", "PROTEIN", 112, 135], ["S1 and S2 subunits", "PROTEIN", 161, 179], ["protease", "PROTEIN", 201, 209], ["SARS", "PROBLEM", 18, 22], ["CoV", "TEST", 23, 26], ["COVID", "TEST", 89, 94], ["the viral spike (S) protein", "PROBLEM", 108, 135], ["SARS", "OBSERVATION", 18, 22], ["viral spike", "OBSERVATION", 112, 123]]], ["5 S1 is responsible for recognizing host receptors, while S2 mediates viral fusion into the cytoplasm.", [["cytoplasm", "ANATOMY", 92, 101], ["5", "ORGANISM", 0, 1], ["S1", "GENE_OR_GENE_PRODUCT", 2, 4], ["S2", "GENE_OR_GENE_PRODUCT", 58, 60], ["cytoplasm", "ORGANISM_SUBSTANCE", 92, 101], ["S1", "PROTEIN", 2, 4], ["host receptors", "PROTEIN", 36, 50], ["S2", "PROTEIN", 58, 60], ["viral fusion", "TREATMENT", 70, 82], ["viral fusion", "OBSERVATION", 70, 82]]], ["6 Angiotensin-converting enzyme-2 (ACE2), a negative regulator of the renin-angiotensin system, is abundant in kidney, lung, and intestine.", [["kidney", "ANATOMY", 111, 117], ["lung", "ANATOMY", 119, 123], ["intestine", "ANATOMY", 129, 138], ["Angiotensin", "CHEMICAL", 2, 13], ["angiotensin", "CHEMICAL", 76, 87], ["Angiotensin-converting enzyme-2", "GENE_OR_GENE_PRODUCT", 2, 33], ["ACE2", "GENE_OR_GENE_PRODUCT", 35, 39], ["renin-angiotensin", "GENE_OR_GENE_PRODUCT", 70, 87], ["kidney", "ORGAN", 111, 117], ["lung", "ORGAN", 119, 123], ["intestine", "ORGAN", 129, 138], ["Angiotensin-converting enzyme-2", "PROTEIN", 2, 33], ["ACE2", "PROTEIN", 35, 39], ["renin", "PROTEIN", 70, 75], ["Angiotensin", "TEST", 2, 13], ["ACE2", "TEST", 35, 39], ["angiotensin system", "OBSERVATION", 76, 94], ["kidney", "ANATOMY", 111, 117], ["lung", "ANATOMY", 119, 123], ["intestine", "ANATOMY", 129, 138]]], ["7 SARS-CoV-2 S1 binds to ACE2 at a high affinity of 8.02 nM.", [["ACE2", "GENE_OR_GENE_PRODUCT", 25, 29], ["SARS-CoV-2 S1", "DNA", 2, 15], ["ACE2", "PROTEIN", 25, 29], ["CoV", "TEST", 7, 10], ["ACE2", "TEST", 25, 29]]], ["8 The cells insensitive to SARS-CoV-2 turn to be susceptible to the virus after transfection with ACE2.", [["cells", "ANATOMY", 6, 11], ["cells", "CELL", 6, 11], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 27, 37], ["ACE2", "GENE_OR_GENE_PRODUCT", 98, 102], ["ACE2", "PROTEIN", 98, 102], ["The cells", "PROBLEM", 2, 11], ["SARS", "PROBLEM", 27, 31], ["CoV", "TEST", 32, 35], ["the virus", "PROBLEM", 64, 73], ["ACE2", "TEST", 98, 102]]]], "PMC7101764": []}